Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jessica Salmen"'
Autor:
Anna Horn, Julia Wendel, Isabella Franke, Armin Bauer, Harald Baumeister, Eileen Bendig, Sara Y. Brucker, Thomas M. Deutsch, Patricia Garatva, Kirsten Haas, Lorenz Heil, Klemens Hügen, Helena Manger, Rüdiger Pryss, Viktoria Rücker, Jessica Salmen, Andrea Szczesny, Carsten Vogel, Markus Wallwiener, Achim Wöckel, Peter U. Heuschmann, the BETTER-CARE Study Group
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background The risk of breast cancer patients for long-term side effects of therapy such as neurotoxicity and cardiotoxicity as well as late effects regarding comorbidities varies from individual to individual. Personalised follow-up care co
Externí odkaz:
https://doaj.org/article/fd61e6d7c0334e868bd4b28a3617d320
Autor:
Florian Ebner, Jessica Salmen, Davut Dayan, Matthias Kiesel, Regine Wolters, Wolfgang Janni, Achim Wöckel, Manfred Wischnewsky
Publikováno v:
Breast Cancer Research and Treatment. 199:173-184
Purpose Although the incidence of distant relapse is decreasing, 20–30% of patients with early breast cancer die of metastasis. The aim of this study is to characterize patients with metastasis-free survival(MFS) less than 5 years, to analyze the m
Autor:
Natascha Fahmer, Hermann Faller, Achim Wöckel, Jessica Salmen, Peter U. Heuschmann, Karin Meng
Publikováno v:
Psycho-Oncology. 32:682-691
Autor:
Sanja, Löb, Eva, Linsmeier, Saskia-Laureen, Herbert, Tanja, Schlaiß, Matthias, Kiesel, Jörg, Wischhusen, Jessica, Salmen, Peter, Kranke, Anne, Quenzer, Florian, Kurz, Claire, Weiss, Elena, Gerhard-Hartmann, Achim, Wöckel, Joachim, Diessner
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Therapeutic options for breast cancer (BC) treatment are constantly evolving. The Human Epidermal Growth Factor 2 (HER2)-low BC entity is a new subgroup, representing about 55% of all BC patients. New antibody–drug conjugates demonstrated p
Autor:
Jessica Salmen
Publikováno v:
Karger Kompass Onkologie. 3:86-87
Hintergrund: Ziel dieser Studie war es, die Lebensqualitat, das Korperbild und die wahrgenommene soziale Unterstutzung bei Frauen nach einer Brustkrebsoperation zu vergleichen. Patienten und Methoden: Patientinnen, die sich einer brusterhaltenden Ope